These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8049423)

  • 1. Progression of the myeloid differentiation program is dominant to transforming growth factor-beta 1-induced apoptosis in M1 myeloid leukemic cells.
    Selvakumaran M; Reed JC; Liebermann D; Hoffman B
    Blood; 1994 Aug; 84(4):1036-42. PubMed ID: 8049423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
    Selvakumaran M; Lin HK; Sjin RT; Reed JC; Liebermann DA; Hoffman B
    Mol Cell Biol; 1994 Apr; 14(4):2352-60. PubMed ID: 8139540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
    Selvakumaran M; Liebermann D; Hoffman-Liebermann B
    Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells.
    Lotem J; Sachs L
    Blood; 1992 Oct; 80(7):1750-7. PubMed ID: 1382703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells.
    Lotem J; Sachs L
    Blood; 1990 Oct; 76(7):1315-22. PubMed ID: 2207308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of type-beta 1 transforming growth factor on the proliferation and differentiation of mouse myelomonocytic leukemia cells (M1).
    Michishita M; Hirayoshi K; Tsuru A; Nakamura N; Yoshida Y; Okuma M; Nagata K
    Exp Cell Res; 1991 Sep; 196(1):107-13. PubMed ID: 1879463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc.
    Hoffman-Liebermann B; Liebermann DA
    Mol Cell Biol; 1991 May; 11(5):2375-81. PubMed ID: 1901940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A).
    Amanullah A; Hoffman B; Liebermann DA
    Blood; 2000 Jul; 96(2):475-82. PubMed ID: 10887108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1.
    Vairapandi M; Balliet AG; Fornace AJ; Hoffman B; Liebermann DA
    Oncogene; 1996 Jun; 12(12):2579-94. PubMed ID: 8700517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
    Hoffman-Liebermann B; Liebermann DA
    Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
    Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells.
    Okabe-Kado J; Honma Y; Hayashi M; Hozumi M
    Jpn J Cancer Res; 1989 Mar; 80(3):228-32. PubMed ID: 2498257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells.
    Zhang J; Shen B; Li Y; Sun Y
    Leuk Res; 2001 Jun; 25(6):463-72. PubMed ID: 11337018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1.
    Tanaka H; Matsumura I; Nakajima K; Daino H; Sonoyama J; Yoshida H; Oritani K; Machii T; Yamamoto M; Hirano T; Kanakura Y
    Blood; 2000 Feb; 95(4):1264-73. PubMed ID: 10666199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between leukemia cells and bone marrow stromal cells: stroma-supported growth vs. serum dependence and the roles of TGF-beta and M-CSF.
    Peled A; Lee BC; Sternberg D; Toledo J; Aracil M; Zipori D
    Exp Hematol; 1996 May; 24(6):728-37. PubMed ID: 8635529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C is not necessary for transforming growth factor beta-induced growth-arrest in leukemia cell lines.
    Manzel L; Macfarlane DE
    Leuk Res; 1997 May; 21(5):403-10. PubMed ID: 9225067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells.
    Smith SI; Weil D; Johnson GR; Boyd AW; Li CL
    Blood; 1998 Feb; 91(3):764-73. PubMed ID: 9446634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.